you should clean your ears a bit: 'double or better' even the CFO said, while low-balling expectations to not create another Melo disaster.
Performance compared w/ current MCAP assuming 64M OS fully diluted -> this stock is very cheap right now.
Recovery should indeed match last purchase price $4.26, equaling $14 pre-dilution or around $1 pre-RS.
When you realize the progress being made incl. production facilities and many not-mentioned items .. you will know what you have bought.
Hint: High overall revenue w/o much collaboration cash, while margins are low due to pending profit shares payout with higher margins. Also: DSM impact 2018-2019.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.